Advertisement
Singapore markets close in 4 hours 28 minutes
  • Straits Times Index

    3,350.76
    +14.17 (+0.42%)
     
  • Nikkei

    38,960.36
    +472.46 (+1.23%)
     
  • Hang Seng

    18,498.33
    +418.72 (+2.32%)
     
  • FTSE 100

    8,275.38
    +44.33 (+0.54%)
     
  • Bitcoin USD

    68,334.58
    +569.98 (+0.84%)
     
  • CMC Crypto 200

    1,475.94
    +47.37 (+3.32%)
     
  • S&P 500

    5,277.51
    +42.03 (+0.80%)
     
  • Dow

    38,686.32
    +574.82 (+1.51%)
     
  • Nasdaq

    16,735.02
    -2.08 (-0.01%)
     
  • Gold

    2,341.90
    -3.90 (-0.17%)
     
  • Crude Oil

    76.93
    -0.06 (-0.08%)
     
  • 10-Yr Bond

    4.5140
    -0.0400 (-0.88%)
     
  • FTSE Bursa Malaysia

    1,596.68
    -7.58 (-0.47%)
     
  • Jakarta Composite Index

    7,074.60
    +103.87 (+1.49%)
     
  • PSE Index

    6,470.79
    +37.69 (+0.59%)
     

Total number of voting rights and capital on January 31, 2024

Novozymes A/S
Novozymes A/S

        

Total number of voting rights and capital on January 31, 2024




January 31, 2024
Company announcement No. 05

 


Referring to company announcement 02, on January 29, 2024, where Novozymes A/S ("Novozymes") announced the completion and final registration with the Danish Business Authority of the statutory merger between Novozymes and Chr. Hansen Holding A/S, the share capital has been increased by nominally DKK 374,597,292 from DKK 562,000,000 to DKK 936,597,292 through the issuance of a total of 187,298,646 new Novozymes B-shares in the denomination of DKK 2 each.

ADVERTISEMENT

Following the above, and pursuant to Article 32 of the Danish Capital Markets Act, it is hereby announced that the total share capital as of today consists of nominally DKK 936,597,292 comprising a total of 468,298,646 shares, divided into 53,743,600 A shares and 414,555,046 B shares with a nominal value of DKK 2 each and a total of 1,903,982,092 voting rights.

 

Nominal Value, DKK

Number of shares

A shares

107,487,200

53,743,600

B shares

829,110,092

414,555,046

Total

936,597,292

468,298,646


Contact information

Investor Relations

 

 

Tobias Bjorklund

+45 3077 8682

tobb@novonesis.com

Anders Enevoldsen

+45 5350 1453

adev@novonesis.com



Media Relations

 

 

Lina Danstrup

+45 3077 0552

lind@novonesis.com

 

 

 


 

Attachment